Signaling pathways
-
BA9222 ImlunestrantSummary: Immunestrant (LY-3484356) is an orally effective and selective estrogen receptor degrader (SERD) with pure antagonistic properties. - BA9223 H3B-6545Summary: H3B-6545 is a potent, orally active, selective estrogen receptor covalent antagonist.
- BA9224 GNE-149Summary: GNE-149 is a potent
- BA9225 DienestrolSummary: A synthetic, nonsteroidal estrogen, an estrogen receptor agonist, used in studies related to menopausal and postmenopausal symptoms.
- BA9226 GDC-0927Summary: A potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist.
- BA9227 GestrinoneSummary: Gestrinone (R2323) is an anabolic steroid hormone.
- BA9228 TrachelosideSummary: Tracheloside is an anti-estrogenic lignan.
-
BA9229 FLTX1Summary: FLTX1 is a fluorescent tamoxifen (Tamoxifen) derivative that specifically labels intracellular Tamoxifen binding sites (estrogen receptors) under permeabilizing and non-permeabilizing conditions. - BA9230 AcolbifeneSummary: Acolbifene (EM-652), the active metabolite of EM800, is an orally active pure anti-estrogen and selective antagonist of the estrogen receptor.
- BA9231 PalazestrantSummary: Palazestrant (OP-1250) is an anti-estrogenic and anti-tumor agent.